All posts by: Michael Zand

About Michael Zand

Stem-Cell Gene Therapy Restores Immune System Response – Immortal News

Continue reading

2015-12-06

Immortal News

StemCell Gene Therapy Restores Immune System Response
Immortal News
All subjects had previously obtained stem cell transplants from a parent and had worsening immune systems. To treat them, the scientists removed stem cells from the patients’ bone marrow and used a lentiviral vector to put a normal IL2RG gene into the
Stemcell gene therapy safe treatment for youths with immunodeficiencyUPI.com
StemCell Gene Therapy Shown to Restore Immunity for Youths with Chinatopix
Gene Therapy Shown To Restore Immunity In Young Adults With Rare Medical Daily
Youth Health Magzine –Morning Ticker –EurekAlert –ClinicalTrials.gov
all 38 news articles »
Continue reading

2015-12-06

Immortal News

StemCell Gene Therapy Restores Immune System Response
Immortal News
All subjects had previously obtained stem cell transplants from a parent and had worsening immune systems. To treat them, the scientists removed stem cells from the patients’ bone marrow and used a lentiviral vector to put a normal IL2RG gene into the
Stemcell gene therapy safe treatment for youths with immunodeficiencyUPI.com
StemCell Gene Therapy Shown to Restore Immunity for Youths with Chinatopix
Gene Therapy Shown To Restore Immunity In Young Adults With Rare Medical Daily
Youth Health Magzine –Morning Ticker –EurekAlert –ClinicalTrials.gov
all 38 news articles »
Continue reading

2015-12-06

Kent and Sussex Courier

East Sussex cat given UK’s first stem cell treatment – to help it poo properly
Kent and Sussex Courier
THE first ever stem cell therapy treatment to be conducted on a cat in the UK took place in East Sussex – to help the animal poo properly. The pioneering procedure – which cost more than £1,500 – was completed at Forest Lodge Veterinary Centre last month.

and more »

Continue reading

2015-12-06

ISRAEL21c

Japan pins hopes on Israeli stemcell tech
ISRAEL21c
Japan pins hopes on Israeli stemcell tech. Fukushima Medical University signs deal with Pluristem Therapeutics to further develop the company’s PLX-R18 cells to treat acute radiation syndrome. By ISRAEL21c Staff December 6, 2015, 10:18 am.

Continue reading

2015-12-05

Analysis Reveals Lnc-RNA Stem Cell Signature in Acute Leukemia
Cancer Therapy Advisor
ORLANDO – Researchers at Hannover Medical School in Hannover, Germany, have established a core long non-coding RNA (lncRNA) stem cell signature in acute myeloid leukemia (AML), a study presented at the American Society of Hematology (ASH) …